首页> 美国卫生研究院文献>Infection and Immunity >Induction of Protective Immunity to Listeria monocytogenes with Dendritic Cells Retrovirally Transduced with a Cytotoxic T Lymphocyte Epitope Minigene
【2h】

Induction of Protective Immunity to Listeria monocytogenes with Dendritic Cells Retrovirally Transduced with a Cytotoxic T Lymphocyte Epitope Minigene

机译:细胞毒性T淋巴细胞表位小基因逆转录病毒转导的树突状细胞对单核细胞增生李斯特菌的保护性免疫诱导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present study, we developed a cytotoxic T lymphocyte (CTL) epitope minigene-transduced dendritic cell (DC)-based vaccine against Listeria monocytogenes. Murine bone marrow-derived DCs were retrovirally transduced with a minigene for listeriolysin O (LLO) 91-99, a dominant CTL epitope of L. monocytogenes, and were injected into BALB/c mice intravenously. We found that the DC vaccine was capable of generating peptide-specific CD8+ T cells exhibiting LLO 91-99-specific cytotoxic activity and gamma interferon production, leading to induction of protective immunity to the bacterium. Furthermore, we demonstrated that the retrovirally transduced DC vaccine was more effective than a CTL epitope peptide-pulsed DC vaccine and a minigene DNA vaccine for eliciting antilisterial immunity. These results provide an alternative strategy in which retrovirally transduced DCs are used to design vaccines against intracellular pathogens.
机译:在本研究中,我们开发了针对李斯特菌的细胞毒性T淋巴细胞(CTL)表位小基因转导的树突细胞(DC)为基础的疫苗。用小基因李斯特菌溶血素O(LLO)91-99(单核细胞增生李斯特氏菌的显性CTL表位)的小基因逆转录转导小鼠骨髓来源的DC,并将其静脉注射到BALB / c小鼠中。我们发现DC疫苗能够产生肽特异性的CD8 + T细胞,这些细胞具有LLO 91-99特异性的细胞毒活性和γ干扰素的产生,从而诱导对该细菌的保护性免疫。此外,我们证明了逆转录病毒转导的DC疫苗比CTL表位肽脉冲DC疫苗和小基因DNA疫苗更能引发抗李斯特菌免疫。这些结果提供了一种替代策略,其中逆转录病毒转导的DC用于设计针对细胞内病原体的疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号